Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.6225
-0.0155 (-2.43%)
Feb 20, 2026, 12:50 PM EST - Market open
MTNB Market Cap
MTNB has a market cap or net worth of $3.99 million as of February 20, 2026. Its market cap has increased by 37.51% in one year.
Market Cap
3.99M
Enterprise Value
886.85K
1-Year Change
37.51%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $3.99M, a decrease of -98.22%. That is a compound annual growth rate of -36.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 4.10M | 7.89% |
| Dec 31, 2025 | 3.80M | 46.15% |
| Dec 31, 2024 | 2.60M | -94.47% |
| Dec 29, 2023 | 47.00M | -56.64% |
| Dec 30, 2022 | 108.40M | -50.37% |
| Dec 31, 2021 | 218.40M | -19.41% |
| Dec 31, 2020 | 271.00M | -26.64% |
| Dec 31, 2019 | 369.40M | 452.17% |
| Dec 31, 2018 | 66.90M | -37.94% |
| Dec 29, 2017 | 107.80M | -51.77% |
| Mar 2, 2017 | 223.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 4.80M |
| Acurx Pharmaceuticals | 4.75M |
| PMGC Holdings | 4.45M |
| Indaptus Therapeutics | 4.35M |
| Cardio Diagnostics Holdings | 4.31M |
| Genprex | 4.28M |
| 60 Degrees Pharmaceuticals | 4.19M |
| Silo Pharma | 3.94M |